Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer

Summary

This clinical study will investigate the utility of PET imaging with \[89Zr\]Panitumumab for imaging of EGFR expression in newly diagnosed colon cancer patients to assess lymph node involvement. If promising, this data will be used to design larger trials.

Timeline

Start

2019-03-14

Primary completion

2025-01

Completion

2026-01

Outcome

Outcome not reported

Stopped (Enrollment): “Study was not able to enroll any subjects”

Drugs

Indications